dc.date.accessioned | 2016-01-08T18:41:22Z | en |
dc.date.available | 2016-01-08T18:41:22Z | en |
dc.date.created | 1979 | en |
dc.date.issued | 1979 | en |
dc.identifier.bibliographicCitation | Washington: U.S. Government Printing Office, 1979. S. 773, 96th Congress, 1st session. Introduced 1979 March 27. Referred to the Committee on Labor and Human Resources | en |
dc.identifier.uri | http://hdl.handle.net/10822/782552 | en |
dc.format | Bill | en |
dc.language | en | en |
dc.publisher | United States. Congress. Senate | en |
dc.source | eweb:26216 | en |
dc.subject | Drug Labeling | en |
dc.subject | Drugs | en |
dc.subject | Food | en |
dc.subject | Insulin | en |
dc.subject | Labeling | en |
dc.subject.classification | Truth-telling | en |
dc.subject.classification | Drugs and Drug Industry | en |
dc.title | A Bill to Amend the Federal Food, Drug and Cosmetic Act to Provide for a Federal Drug Compendium Which Provides Reliable, Complete, and Readily Accessible Prescribing Information; to Assure Safety and Efficacy of Drugs Through Certification Of Certain Drugs Other Than Insulin and Antibiotics; to Require Certain Information in Drug Labeling; and to Improve the Administration and Enforcement of the Act as It Relates to Drugs | en |
dc.provenance | Citation prepared by the Library and Information Services group of the Kennedy Institute of Ethics, Georgetown University for the ETHXWeb database. | en |
dc.provenance | Citation migrated from OpenText LiveLink Discovery Server database named EWEB hosted by the Bioethics Research Library to the DSpace collection EthxWeb hosted by DigitalGeorgetown. | en |